Socio-economic inequalities in stage at diagnosis, and in time intervals on the lung cancer pathway from first symptom to treatment: systematic review and meta-analysis
- PMID: 27682330
- PMCID: PMC5390856
- DOI: 10.1136/thoraxjnl-2016-209013
Socio-economic inequalities in stage at diagnosis, and in time intervals on the lung cancer pathway from first symptom to treatment: systematic review and meta-analysis
Abstract
Cancer diagnosis at an early stage increases the chance of curative treatment and of survival. It has been suggested that delays on the pathway from first symptom to diagnosis and treatment may be socio-economically patterned, and contribute to socio-economic differences in receipt of treatment and in cancer survival. This review aimed to assess the published evidence for socio-economic inequalities in stage at diagnosis of lung cancer, and in the length of time spent on the lung cancer pathway. MEDLINE, EMBASE and CINAHL databases were searched to locate cohort studies of adults with a primary diagnosis of lung cancer, where the outcome was stage at diagnosis or the length of time spent within an interval on the care pathway, or a suitable proxy measure, analysed according to a measure of socio-economic position. Meta-analysis was undertaken when there were studies available with suitable data. Of the 461 records screened, 39 papers were included in the review (20 from the UK) and seven in a final meta-analysis for stage at diagnosis. There was no evidence of socio-economic inequalities in late stage at diagnosis in the most, compared with the least, deprived group (OR=1.04, 95% CI=0.92 to 1.19). No socio-economic inequalities in the patient interval or in time from diagnosis to treatment were found. Socio-economic inequalities in stage at diagnosis are thought to be an important explanatory factor for survival inequalities in cancer. However, socio-economic inequalities in stage at diagnosis were not found in a meta-analysis for lung cancer.
Prospero protocol registration number: CRD42014007145.
Keywords: Lung Cancer.
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.
Conflict of interest statement
We declare that we have no competing interests.
Figures
Comment in
-
Socioeconomic position and delays in lung cancer diagnosis: should we target the more deprived?Thorax. 2017 May;72(5):393-395. doi: 10.1136/thoraxjnl-2016-209591. Epub 2016 Dec 19. Thorax. 2017. PMID: 27993958 No abstract available.
References
-
- Tørring ML, Frydenberg M, Hansen RP, et al. Evidence of increasing mortality with longer diagnostic intervals for five common cancers: A cohort study in primary care. European Journal of Cancer. 2013;49(9):2187–98. - PubMed
-
- Cancer Research UK. Cancer incidence: UK statistics [18/12/13] Available from: http://info.cancerresearchuk.org/cancerstats/incidence/
-
- Howlader N, N A, Krapcho M, Neyman N, et al. KA SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations) National Cancer Institute; Bethesda, MD: 2011. based on November 2011 SEER data submission, posted to SEER web site 2]. Available from: http://seer.cancer.gov/csr/1975_2009_pops09/
-
- Cancer Research UK. Common cancers - UK mortality statistics [18/12/13] Available from: http://info.cancerresearchuk.org/cancerstats/mortality/cancerdeaths/
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical